Enanta Pharmaceuticals (ENTA) Return on Sales [ROS] (2012 - 2026)
Enanta Pharmaceuticals' Return on Sales [ROS] was -120.04% in fiscal Q3 2026 (quarter ended Jun 30, 2026), down 16.87 percentage points from -103.16% a year earlier and down 50.96 percentage points from the prior quarter.
Enanta Pharmaceuticals (ENTA) Return on Sales [ROS] (2012 - 2026) Analysis & Trends
On a trailing twelve-month basis, Enanta Pharmaceuticals' Return on Sales [ROS] was -89.99% through Jun 30, 2026, up 59.40 percentage points year-over-year; for FY2025 (ended Sep 30, 2025), it was -130.65%, up 49.27 percentage points from FY2024.
- Return on Sales [ROS] shows a five-year change of -96.66 percentage points (FY2020 to FY2025).
- In earlier fiscal years, Return on Sales [ROS] was -179.92% in FY2024 (-6.69 pp), -173.23% in FY2023 (-29.50 pp), -143.74% in FY2022 (-30.86 pp) and -112.88% in FY2021 (-78.88 pp).
- Quarterly Return on Sales [ROS] has moved between -221.70% (fiscal Q2 2023) and -60.45% (fiscal Q1 2026) over five years.
- Compared with a year earlier, Return on Sales [ROS] was higher in six of the last eight quarters, with an average year-over-year change of +39.16 percentage points.
- The best year-over-year quarter for Return on Sales [ROS] over five years was fiscal Q2 2026 (a gain of 95.25 percentage points); the worst was fiscal Q1 2022 (a drop of 71.24 percentage points).
- Per Business Quant data, ENTA's Return on Sales [ROS] in the three fiscal quarters before Q3 2026 was -69.07% (Q2 2026), -60.45% (Q1 2026) and -121.56% (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 28.21% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 28.37% |
| 10 | Enanta Pharmaceuticals | 377.40 Mn | -350.60 Mn | - | -120.04% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -120.04% |
| Mar 31, 2026 | -69.07% |
| Dec 31, 2025 | -60.45% |
| Sep 30, 2025 | -121.56% |
| Jun 30, 2025 | -103.16% |
| Mar 31, 2025 | -164.32% |
| Dec 31, 2024 | -138.82% |
| Sep 30, 2024 | -204.38% |
| Jun 30, 2024 | -134.58% |
| Mar 31, 2024 | -192.13% |
| Dec 31, 2023 | -193.78% |
| Sep 30, 2023 | -163.90% |
| Jun 30, 2023 | -194.33% |
| Mar 31, 2023 | -221.70% |
| Dec 31, 2022 | -127.25% |
| Sep 30, 2022 | -133.13% |
| Jun 30, 2022 | -167.05% |
| Mar 31, 2022 | -180.85% |
| Dec 31, 2021 | -109.99% |
| Sep 30, 2021 | -143.06% |
Enanta Pharmaceuticals Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=ENTA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "ENTA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=ENTA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();